Skip to content

MagnezixKids Study

Magnesium-based, Bioresorbable Implants for Pediatric Elbow Fractures, a Single Center Pilot Study for Osteosynthesis With Magnezix Screws in Fractures of the Epicondylus Ulnaris and Condylus Radialis.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04571905
Enrollment
17
Registered
2020-10-01
Start date
2020-08-01
Completion date
2023-07-12
Last updated
2023-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bioresrobable Implants, Childhood, Elbow Fracture, Magnesium-based, Magnezix, Osteosynthesis, Pediatric Elbow Fractures

Brief summary

The overall objective of the study is to describe the outcomes of osteosyn-thesis with magnesium based screws in children with a primary or second-ary (within 7 days from trauma) dislocated fracture of the Epicondyles ul-naris or Condylus radialis, and to compare them with outcomes of conven-tional osteosynthesis using steel screws. If our results suggest non-inferiority of osteosynthesis with magnesium-based screws, the procedure could be tested formally in a subsequent full-size study.

Interventions

DEVICEOsteosynthesis with resorbable Material

Osteosynthesis with Magnezix screws in fractures of the Epicondylus ulnaris and Condylus radialis under General anaesthesia

Sponsors

Thomas Krebs
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* primary or secondary (within 7 days from trauma) dislocated fracture of the Epicondyles ulnaris or Condylus radialis (indication for operative treatment according to international standard: Dislocation of more than 2 mm in Condylus radials fractures and more than 5 mm in Epicondylus ulnas fractures ) * Age 3-15 years * Informed Consent as documented by signature

Exclusion criteria

* \- open fractures or complex multi fragment fractures that require dif-ferent osteosynthetic procedures than screw fixation * severe local accompanying injury (injury to nerves/vessels) * polytrauma patients * fracture age \> 7 days * preexisting ipsilateral elbow fracture * relevant comorbidities, which have influence on fracture and wound healing * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant or the legal representatives * Previous enrolment into the current study * Enrolment of the investigator's family members and other dependent persons * Any of the following applicable absolute and relative contraindica-tions listed in the MAGNEZIX® CBS and CSc 4.8 mm instruction for use : Absolute contraindications: * insufficient or avascular bone mass for anchorage of the implant, ex-cept osteochondral fractures and dissecates * confirmation or suspected septic infectious surgical site * application in the area of the epiphyseal plates Relative contraindications: * acute sepsis * alcohol, nicotine and/or drug abuse * epilepsy * poor skin/soft tissue conditions * uncooperative patient or patient with restricted intellectual capacity * no options for adequate postoperative treatment (e.g. temporary strain relief)

Design outcomes

Primary

MeasureTime frameDescription
Clinical and radiologic outcome (fracture consolidation)12 monthsradiologic outcome after osteosynthesis with magnesium based screws in children with a primary or secondary (within 7 days from trauma) dislocated fracture of the Epicondyles ulnaris or Condylus radialis Fracture alignment is measured as dislocation distance (mm). Appropriate alignement is a postopera-tive dehiscence or dislocation of less than 5 mm in Epicondylus ulnaris fractures and less than 2 mm in Condylus radialis fractures, according to literature (26/27/31).

Secondary

MeasureTime frameDescription
Woundhealing12 monthsClinical reassessment at Routine follow-ups at every study visit \- Classification in normal or delayed/impaired. Signs for im-pairment are local secretion, swelling, reddening or wound dehiscence.
Clinical fracture consolidation after one year12 monthsClinical reassessment at Routine follow-ups at every study visit \- Clinical signs for good consolidation are: no pain while palpating the fracture site.
Analgesic reuirement12 monthsAnalgesic requirement via Pain score (Visual Analog Scale, VAS, Range from 1 (no pain) to 10 (strongest pain)) (27) at every study visit (except visit 1: preop. assessment)
ROM12 monthsClinical reassessment at Routine follow-ups at every study visit \- An Arc \>100° shows a good functional result, arc 50-100° is a fair (acceptable) result, arc \<50° shows a poor (unsatisfactory) result, according to the Mayo elbow performance index (see appendix).

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026